[1]
|
Hafler, D.A. (2004) Multiple sclerosis. Journal of Clinical Investigation, 113, 788-794.
|
[2]
|
Barnett, M.H. and Prineas, J.W. (2004) Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Annals of Neurology, 55, 458-468.
doi:10.1002/ana.20016
|
[3]
|
Kornek, B. and Lassmann, H. (2003) Neuropathology of multiple sclerosis-new concepts. Brain Research Bulletin, 61, 321-326. doi:10.1016/S0361-9230(03)00095-9
|
[4]
|
Hogancamp, W.E., Rodriguez, M. and Weinshenker, B.G. (1997) The epidemiology of multiple sclerosis. Mayo Clinic Proceedings, 72, 871-878.
doi:10.4065/72.9.871
|
[5]
|
Olerup, O. and Hillert, J. (1991) HLA class II-associated genetic susceptibility in multiple sclerosis: A critical evaluation. Tissue Antigens, 38, 1-15.
doi:10.1111/j.1399-0039.1991.tb02029.x
|
[6]
|
Akesson, E., Oturai, A., Berg, J., Fredrikson, S., Andersen, O., Harbo, H.F., Laaksonen, M., Myhr, K.M., Nyland, H.I., Ryder, L.P., Sandberg-Wollheim, M., Sorensen, P.S., Spurkland, A., Svejgaard, A., Holmans, P., Compston, A., Hillert, J. and Sawcer, S. (2002) A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immunity, 3, 279-285.
doi:10.1038/sj.gene.6363866
|
[7]
|
Wasay, M., Khatri, I.A., Khealani, B. and Sheerani, M. (2006) MS in Asian countries. International MS Journal, 13, 58-65.
|
[8]
|
Kira, J., Yamasaki, K., Horiuchi, I., Ohyagi, Y., Taniwaki, T. and Kawano, Y. (1999) Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. Journal of the Neurological Sciences, 166, 53-57.
doi:10.1016/S0022-510X(99)00115-X
|
[9]
|
Kira, J., Kanai, T., Nishimura, Y., Yamasaki, K., Matsushita, S., Kawano, Y., Hasuo, K., Tobimatsu, S. and Kobayashi, T. (1996) Western versus Asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders. Annals of Neurology, 40, 569-574.
doi:10.1002/ana.410400405
|
[10]
|
Fukazawa, T., Kikuchi, S., Miyagishi, R., Miyazaki, Y., Yabe, I., Hamada, T. and Sasaki, H. (2006) HLA- dPB1*0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients. Important role of DPB1*0301. Multiple Sclerosis, 12, 19-23.
doi:10.1191/135248506ms1252oa
|
[11]
|
Matsuoka, T., Matsushita, T., Osoegawa, M., Ochi, H., Kawano, Y., Mihara, F., Ohyagi, Y. and Kira, J. (2008) Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. Journal of the Neurological Sciences, 266, 115-125.
doi:10.1016/j.jns.2007.09.010
|
[12]
|
Kalanie, H., Kholghie, Y., Shamsai, G.R. and Ghorbani, M. (2009) Opticospinal multiple sclerosis in Iran. Journal of the Neurological Sciences, 276, 130-132.
doi:10.1016/j.jns.2008.09.038
|
[13]
|
Kuroiwa, Y., Igata, A., Itahara, K., Koshijima, S. and Tsubaki, T. (1975) Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1084 cases. Neurology, 25, 845-851.
|
[14]
|
Houzen, H., Niino, M., Kikuchi, S., Fukazawa, T., Nogoshi, S., Matsumoto, H. and Tashiro, K. (2003) The prevalence and clinical characteristics of MS in northern Japan. Journal of the Neurological Sciences, 211, 49-53.
|
[15]
|
Zhao, B. X., Liu, X. Q., Guo, Y. P., Yang, Y. C. and Huang, H. F. (1981) Multiple sclerosis. A clinical study of 70 cases. European Neurology, 20, 394-400.
|
[16]
|
Hung, T.P., Landsborough, D. and Hsi, M.S. (1976) Multiple sclerosis amongst Chinese in Taiwan. Journal of the Neurological Sciences, 27, 459-484.
doi:10.1016/0022-510X(76)90214-8
|
[17]
|
Das, A. and Puvanendran, K. (1998) A retrospective review of patients with clinically definite multiple sclerosis. Annals, Academy of Medicine, Singapore, 27, 204-209.
|
[18]
|
Jitpimolmard, S. and Vejjajiva, A. (1994) Clinical features and clinical course of multiple sclerosis in Thai patients: A report of 50 cases. Journal of The Medical Association of Thailand, 77, 239-243.
|
[19]
|
Kurtzke, J.F., Park, C.S. and Oh, S.J. (1968) Multiple sclerosis in Korea. Clinical features and prevalence. Journal of the Neurological Sciences, 6, 463-481.
doi:10.1016/0022-510X(68)90031-2
|
[20]
|
Tan, C.T. (1998) Multiple sclerosis in Malaysia. Archives of Neurology, 45, 624-627.
|
[21]
|
Kalanie, H., Gharagozli, K. and Kalanie, A.R. (2003) Multiple sclerosis: Report on 200 cases from Iran. Multiple Sclerosis, 9, 36-38. doi:10.1191/1352458503ms887oa
|
[22]
|
Kalanie, H., Kamgooyan, M., Sadeghian, H. and Kalanie A.R. (2000) Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran. Multiple Sclerosis, 6, 317-319.
|
[23]
|
Massey, H.D. and McPherson, R.A. (2007) The major histocompatibility complex of man. In: McPherson R.A. and Pincus M.R. Eds., Henry’s clinical diagnosis and management by laboratory methods. 21st Edition, Saunders Elsevier, Beijing, 876-893.
|
[24]
|
Julio, C.D. and Edmond, J.Y. (2007) The Major Histocompatibility Complex and Disease. In Henry’s Clinical Diagnosis and Management by Laboratory Methods, Saunders-Elsevier, 21st Edition, 8, 894-902.
|
[25]
|
Misu, T., Fujihara, K., Nakashima, I., Miyazawa, I., Okita, N., Takase, S. and Itoyama, Y. (2002) Pure optic-spinal form of multiple sclerosis in Japan. Brain, 125, 2460-2468. doi:10.1093/brain/awf260
|
[26]
|
Nakashima, I., Fukazawa, T., Ota, K., Nohara, C., Warabi, Y., Ohashi, T., Miyazawa, I., Fujihara, K. and Itoyama, Y. (2007) Two subtypes of optic-spinal form of multiple sclerosis in Japan: Clinical and laboratory features. Journal of Neurology, 254, 488-492.
doi:10.1007/s00415-006-0400-z
|
[27]
|
Matsuoka, T., Matsushita, T., Osoegawa, M., Kawano, Y., Minohara, M., Mihara, F., Nishimura, Y., Ohyagi, Y. and Kira, J. (2008) Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis. Multiple Sclerosis, 14, 1181-1190.
doi:10.1177/1352458508097818
|
[28]
|
Brum, D.G., Barreira, A.A., Santos dos, A.C., Kaimen-Maciel, D.R., Matiello, M., Costa, R.M., Deghaide, N.H., Costa, L.S., Louzada-Junior, P., Diniz, P.R., Comini-Frota, E.R., Mendes-Junior, C.T. and Donadi, E.A. (2010) HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Multiple Sclerosis, 16, 21-29.
doi:10.1177/1352458509350741
|
[29]
|
Weinshenker, B.G. and Wingerchuk, D.M. Neuromyelitis optica: Clinical syndrome and the NMO-IgG autoantibody marker. Current Topics in Microbiology and Immunology, 318, 343-356.
doi:10.1007/978-3-540-73677-6_14
|
[30]
|
Kira, J. (2008) Neuromyelitis optica and Asian phenotype of multiple sclerosis. Annals of the New York Academy of Sciences, 1142, 58-71.
doi:10.1196/annals.1444.002
|
[31]
|
Nandhagopal, R., Al-Asmi, A. and Gujjar, A.R. (2010) Neuromyelitis optica: An overview. Postgraduate Medical Journal, 86, 153-159. doi:10.1136/pgmj.2009.091389
|